WILMINGTON, DE / ACCESSWIRE / March 28, 2023 / Transparency Market Research Inc. - The pulmonary valve replacement market was valued at USD 1.0 Bn in 2022 and is projected to surpass USD 1.6 Bn by ...

The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...

Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for patients with severe pulmonary regurgitation. According to a company press release, the ...

Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The worldwide market for transcatheter pulmonary valve replacement reached a value of USD 44.62 Million in 2022. As per the most recent assessment ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio At 10 years, transcatheter pulmonary ...

Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

University of MIchigan Health C.S. Mott Children's Hospital, part of Ann Arbor-based Michigan Medicine, is among the first in the U.S. to perform a catheter-based pulmonary valve replacement on a ...

HANGZHOU, China, Feb. 5, 2024 /CNW/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that, ...

Dublin, July 10, 2020 (GLOBE NEWSWIRE) -- The "Global Transcatheter Pulmonary Valve Replacement (TPVR) Market - Analysis by Application Type, by End User, by Region, by Country (2020 Edition): Market ...

Device preparation for downsizing the diameter of the pulmonary trunk. We designed and developed a self-expandable stent constructed from a single 0.22-mm nitinol wire in the shape of a conduit with a ...

Thus, the pattern of the resolution of pulmonary vascular disease after mitral-valve surgery is not clear. Furthermore, the influence of cardiopulmonary bypass and the characteristics of the ...